Selected article for: "evidence level and moderate pneumonia"
Author: Lee, Mi Suk; Oh, Jee Youn; Kang, Cheol-In; Kim, Eu Suk; Park, Sunghoon; Rhee, Chin Kook; Jung, Ji Ye; Jo, Kyung-Wook; Heo, Eun Young; Park, Dong-Ah; Suh, Gee Young; Kiem, Sungmin
Title: Guideline for Antibiotic Use in Adults with Community-acquired Pneumonia
  • Document date: 2018_6_26
    • ID: sl4u8e6e_142
    Snippet: • Use of β-lactam antibiotics or respiratory fluoroquinolones is recommended in the empirical treatment of patients with mild to moderate pneumonia admitted to a general ward (level of recommendation: weak, level of evidence: moderate)......
    Document: • Use of β-lactam antibiotics or respiratory fluoroquinolones is recommended in the empirical treatment of patients with mild to moderate pneumonia admitted to a general ward (level of recommendation: weak, level of evidence: moderate).

    Search related documents:
    Co phrase search for related documents
    • empirical treatment and respiratory fluoroquinolone: 1, 2
    • evidence level and general ward: 1, 2
    • evidence level and β lactam antibiotic: 1
    • evidence level and moderate weak evidence level: 1, 2, 3, 4, 5
    • evidence level and recommendation level: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • evidence level and respiratory fluoroquinolone: 1
    • evidence level and weak evidence level: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
    • β lactam antibiotic and recommendation level: 1
    • β lactam antibiotic and weak evidence level: 1
    • moderate weak evidence level and recommendation level: 1, 2, 3, 4
    • moderate weak evidence level and weak evidence level: 1, 2, 3, 4, 5
    • recommendation level and respiratory fluoroquinolone: 1
    • recommendation level and weak evidence level: 1, 2, 3, 4, 5, 6, 7, 8, 9